BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30909217)

  • 1. Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.
    Aiello Bowles EJ; Crane PK; Walker RL; Chubak J; LaCroix AZ; Anderson ML; Rosenberg D; Keene CD; Larson EB
    J Alzheimers Dis; 2019; 68(3):1071-1083. PubMed ID: 30909217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
    Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
    Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition.
    Negash S; Wilson RS; Leurgans SE; Wolk DA; Schneider JA; Buchman AS; Bennett DA; Arnold SE
    Curr Alzheimer Res; 2013 Oct; 10(8):844-51. PubMed ID: 23919768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
    Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
    Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of deep learning to understand resilience to Alzheimer's disease pathology.
    Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY
    Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms.
    de Vries LE; Huitinga I; Kessels HW; Swaab DF; Verhaagen J
    Mol Neurodegener; 2024 Apr; 19(1):33. PubMed ID: 38589893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology.
    Negash S; Xie S; Davatzikos C; Clark CM; Trojanowski JQ; Shaw LM; Wolk DA; Arnold SE
    Alzheimers Dement; 2013 May; 9(3):e89-95. PubMed ID: 23127468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.
    Robinson JL; Corrada MM; Kovacs GG; Dominique M; Caswell C; Xie SX; Lee VM; Kawas CH; Trojanowski JQ
    Acta Neuropathol; 2018 Sep; 136(3):377-388. PubMed ID: 29916037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Eissman JM; Dumitrescu L; Mahoney ER; Smith AN; Mukherjee S; Lee ML; Scollard P; Choi SE; Bush WS; Engelman CD; Lu Q; Fardo DW; Trittschuh EH; Mez J; Kaczorowski CC; Hernandez Saucedo H; Widaman KF; Buckley RF; Properzi MJ; Mormino EC; Yang HS; Harrison TM; Hedden T; Nho K; Andrews SJ; Tommet D; Hadad N; Sanders RE; Ruderfer DM; Gifford KA; Zhong X; Raghavan NS; Vardarajan BN; ; ; ; Pericak-Vance MA; Farrer LA; Wang LS; Cruchaga C; Schellenberg GD; Cox NJ; Haines JL; Keene CD; Saykin AJ; Larson EB; Sperling RA; Mayeux R; Cuccaro ML; Bennett DA; Schneider JA; Crane PK; Jefferson AL; Hohman TJ
    Brain; 2022 Jul; 145(7):2541-2554. PubMed ID: 35552371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive resilience and severe Alzheimer's disease neuropathology.
    Ahangari N; Fischer CE; Schweizer TA; Munoz DG
    Aging Brain; 2023; 3():100065. PubMed ID: 36911256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer's disease.
    Morgan GR; Carlyle BC
    Sci Rep; 2024 Mar; 14(1):7161. PubMed ID: 38531951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics.
    Carlyle BC; Kandigian SE; Kreuzer J; Das S; Trombetta BA; Kuo Y; Bennett DA; Schneider JA; Petyuk VA; Kitchen RR; Morris R; Nairn AC; Hyman BT; Haas W; Arnold SE
    Neurobiol Aging; 2021 Sep; 105():99-114. PubMed ID: 34052751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response.
    de Vries LE; Jongejan A; Monteiro Fortes J; Balesar R; Rozemuller AJM; Moerland PD; Huitinga I; Swaab DF; Verhaagen J
    Acta Neuropathol Commun; 2024 Apr; 12(1):68. PubMed ID: 38664739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project.
    Wallace LMK; Theou O; Godin J; Andrew MK; Bennett DA; Rockwood K
    Lancet Neurol; 2019 Feb; 18(2):177-184. PubMed ID: 30663607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.
    Yu L; Wilson RS; Schneider JA; Bennett DA; Boyle PA
    J Alzheimers Dis; 2017; 56(4):1485-1493. PubMed ID: 28157101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.
    Driscoll I; Resnick SM; Troncoso JC; An Y; O'Brien R; Zonderman AB
    Ann Neurol; 2006 Dec; 60(6):688-95. PubMed ID: 17192929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
    Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
    JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.
    Buciuc M; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Boeve BF; Knopman DS; Parisi JE; Petersen RC; Dickson DW; Josephs KA
    Neurobiol Aging; 2020 Aug; 92():92-97. PubMed ID: 32408057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
    Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
    Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.